IFNA1 and cancer: Given the gigantic progress made in the past decade in biomedical research in intratumoral delivery of immunotherapies (including viral vector-mediated delivery), mRNA platforms, and combination therapy, we believe that IFN-based drugs will experience a renewed lease of life, giving hope to cancer patients.